Why the sci-fi dream of cryonics never died – MIT Technology Review
The environment was something of a shift for Drake, who had spent the previous seven years as the medical response director of the Alcor Life Extension Foundation. Though it was the longtime leader in cryonics, Alcor was still a small nonprofit. It had been freezing the bodies and brains of its members, with the idea of one day bringing them back to life, since 1976.
The foundation, and cryonics in general, had long survived outside of mainstream acceptance. Typically shunned by the scientific community, cryonics is best known for its appearance in sci-fi films like 2001: A Space Odyssey. But its adherents have held on to a dream that at some point in the future, advances in medicine will allow for resuscitation and additional years on Earth. Over decades, small, tantalizing developments in related technology, as well as high-profile frozen test subjects like Ted Williams, have kept the hope alive. Today, nearly 200 dead patients are frozen in Alcors cryogenic chambers at temperatures of 196 C, including a handful of celebrities, who have paid tens of thousands of dollars for the goal of possible revival and ultimately reintegration into society.
But its the recent involvement of Yinfeng that signals something of a new era for cryonics. With impressive financial resources, government support, and scientific staff, its one of a handful of new labs focused on expanding the consumer appeal of cryonics and trying anew to bring credibility to the long-disputed theory of human reanimation. Just a year after Drake came on board as research director of the Shandong Yinfeng Life Science Research Institute, the subsidiary of the Yinfeng Biological Group overseeing the cryonics program, the institute performed its first cryopreservation. Its storage vats now hold about a dozen clients who are paying upwards of $200,000 to preserve the whole body.
Still, the field remains rooted in faith rather than any real evidence that it works. Its a hopeless aspiration that reveals an appalling ignorance of biology, says Clive Coen, a neuroscientist and professor at Kings College London.
Even if one day you could perfectly thaw a frozen human body, you would still just have a warm dead body on your hands.
The cryonics process typically goes something like this: Upon a persons death, a response team begins the process of cooling the corpse to a low temperature and performs cardiopulmonary support to sustain blood flow to the brain and organs. Then the body is moved to a cryonics facility, where an organ preservation solution is pumped through the veins before the body is submerged in liquid nitrogen. This process should commence within one hour of deaththe longer the wait, the greater the damage to the bodys cells. Then, once the frozen cadaver is ensconced in the cryogenic chamber, the hope of the dead begins.
Since its beginnings in the late 1960s, the field has attracted opprobrium from the scientific community, particularly its more respectable cousin cryobiologythe study of how freezing and low temperatures affect living organisms and biological materials. The Society for Cryobiology even banned its members from involvement in cryonics in the 1980s, with a former society president lambasting the field as closer to fraud than either faith or science.
In recent years, though, it has grabbed the attention of the libertarian techno-optimist crowd, mostly tech moguls dreaming of their own immortality. And a number of new startups are expanding the playing field. Tomorrow Biostasis in Berlin became the first cryonics company in Western Europe in 2019, for example, and in early 2022, Southern Cryonics opened a facility in Australia.
More researchers are open to longer-term, futuristic topics than there might have been 20 years ago or so, says Tomorrow Biostasis founder Emil Kendziorra.
Here is the original post:
Why the sci-fi dream of cryonics never died - MIT Technology Review
Recommendation and review posted by Bethany Smith
International Cryonics Museum has been chosen as the Sight of the Week by the editors of Roadside America. – Estes Park Trail-Gazette
International Cryonics Museum has been chosen as the Sight of the Week by the editors of Roadside America. Estes Park Trail-Gazette
Recommendation and review posted by Bethany Smith
In case you missed it, link below to the CBS Sunday Morning segment about the Cryonics Museum – Estes Park Trail-Gazette
In case you missed it, link below to the CBS Sunday Morning segment about the Cryonics Museum Estes Park Trail-Gazette
Recommendation and review posted by Bethany Smith
Growth of the U.S. DTC Genetic Testing Market | Personalized Nutrition Medicine – Medriva
Growth of the U.S. DTC Genetic Testing Market | Personalized Nutrition Medicine Medriva
Here is the original post:
Growth of the U.S. DTC Genetic Testing Market | Personalized Nutrition Medicine - Medriva
Recommendation and review posted by Bethany Smith
Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro – ZAWYA
Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro ZAWYA
The rest is here:
Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro - ZAWYA
Recommendation and review posted by Bethany Smith
Abu Dhabi Stem Cells Centre partners with Rege Nephro and Kyoto University’s Center for iPS Cell Research and … – Abu Dhabi Media Office
Abu Dhabi Stem Cells Centre partners with Rege Nephro and Kyoto University's Center for iPS Cell Research and ... Abu Dhabi Media Office
Recommendation and review posted by Bethany Smith
Donating Bone Marrow and Stem Cells: The Process and What To Expect – On Cancer – Memorial Sloan Kettering
Donating Bone Marrow and Stem Cells: The Process and What To Expect On Cancer - Memorial Sloan Kettering
Excerpt from:
Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering
Recommendation and review posted by Bethany Smith
Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic … – Nature.com
See original here:
Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic ... - Nature.com
Recommendation and review posted by Bethany Smith
Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates … – Yahoo Finance
Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates ... Yahoo Finance
See original here:
Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates ... - Yahoo Finance
Recommendation and review posted by Bethany Smith
The Key to Creating Blood Stem Cells May Lie in Your Own Blood – ScienceAlert
The Key to Creating Blood Stem Cells May Lie in Your Own Blood ScienceAlert
More:
The Key to Creating Blood Stem Cells May Lie in Your Own Blood - ScienceAlert
Recommendation and review posted by Bethany Smith
Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference – Yahoo Finance
Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference Yahoo Finance
Continued here:
Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Recommendation and review posted by Bethany Smith
The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an … – Nature.com
Recommendation and review posted by Bethany Smith
A California Man With Leukemia Has a Perfect Match for Bone Marrow Donation. But the US Isn’t Letting His Cousin … – The Messenger
A California Man With Leukemia Has a Perfect Match for Bone Marrow Donation. But the US Isn't Letting His Cousin ... The Messenger
Go here to see the original:
A California Man With Leukemia Has a Perfect Match for Bone Marrow Donation. But the US Isn't Letting His Cousin ... - The Messenger
Recommendation and review posted by Bethany Smith
Attitude, Practices, and Barriers to Menopausal Hormone Therapy Among Physicians in Saudi Arabia – Cureus
Attitude, Practices, and Barriers to Menopausal Hormone Therapy Among Physicians in Saudi Arabia Cureus
Go here to read the rest:
Attitude, Practices, and Barriers to Menopausal Hormone Therapy Among Physicians in Saudi Arabia - Cureus
Recommendation and review posted by Bethany Smith
Kris Tyson Showed Her Transformation One Year After Starting Hormone Replacement Therapy – Yahoo Entertainment
Kris Tyson Showed Her Transformation One Year After Starting Hormone Replacement Therapy Yahoo Entertainment
See the original post here:
Kris Tyson Showed Her Transformation One Year After Starting Hormone Replacement Therapy - Yahoo Entertainment
Recommendation and review posted by Bethany Smith
Understanding Hypogonadism, Testosterone Replacement Therapy, and Prostate Cancer Risk – Medriva
Understanding Hypogonadism, Testosterone Replacement Therapy, and Prostate Cancer Risk Medriva
See the original post here:
Understanding Hypogonadism, Testosterone Replacement Therapy, and Prostate Cancer Risk - Medriva
Recommendation and review posted by Bethany Smith
Arbor, 4DMT partner on new gene therapies in ALS, other diseases – ALS News Today
Arbor, 4DMT partner on new gene therapies in ALS, other diseases ALS News Today
Read the original here:
Arbor, 4DMT partner on new gene therapies in ALS, other diseases - ALS News Today
Recommendation and review posted by Bethany Smith
Gene Therapy Approvals Expected to Ramp Up in 2024 Amid Manufacturing, Cost Challenges – BioSpace
Gene Therapy Approvals Expected to Ramp Up in 2024 Amid Manufacturing, Cost Challenges BioSpace
Read more from the original source:
Gene Therapy Approvals Expected to Ramp Up in 2024 Amid Manufacturing, Cost Challenges - BioSpace
Recommendation and review posted by Bethany Smith
The year of gene therapy? FDA’s Marks calls for solutions to regulatory, manufacturing challenges – BioWorld Online
The year of gene therapy? FDA's Marks calls for solutions to regulatory, manufacturing challenges BioWorld Online
See the original post:
The year of gene therapy? FDA's Marks calls for solutions to regulatory, manufacturing challenges - BioWorld Online
Recommendation and review posted by Bethany Smith
Turning On Gene Therapy with the pA Regulator – RegMedNet
Turning On Gene Therapy with the pA Regulator RegMedNet
See the article here:
Turning On Gene Therapy with the pA Regulator - RegMedNet
Recommendation and review posted by Bethany Smith
Revolutionizing Healthcare: Gene Therapy Market Projected to Reach USD 46.5 billion by 2030 at a 22. – PharmiWeb.com
Revolutionizing Healthcare: Gene Therapy Market Projected to Reach USD 46.5 billion by 2030 at a 22. PharmiWeb.com
Read the rest here:
Revolutionizing Healthcare: Gene Therapy Market Projected to Reach USD 46.5 billion by 2030 at a 22. - PharmiWeb.com
Recommendation and review posted by Bethany Smith
Regeneron CEO Reveals the Game-Changing Potential of Gene Therapy in Biotech! – BioTecNika
Regeneron CEO Reveals the Game-Changing Potential of Gene Therapy in Biotech! BioTecNika
See more here:
Regeneron CEO Reveals the Game-Changing Potential of Gene Therapy in Biotech! - BioTecNika
Recommendation and review posted by Bethany Smith
Bayer’s AskBio checks off another early win for gene therapy platform with Parkinson’s safety data – FierceBiotech
Bayer's AskBio checks off another early win for gene therapy platform with Parkinson's safety data FierceBiotech
Recommendation and review posted by Bethany Smith
What It Means That Lisa Rinna Is On HRT For Menopause – Women’s Health
What It Means That Lisa Rinna Is On HRT For Menopause Women's Health
See more here:
What It Means That Lisa Rinna Is On HRT For Menopause - Women's Health
Recommendation and review posted by Bethany Smith
Lisa Rinna Was Initially ‘Very Scared’ of Hormone Replacement Therapy. She Isn’t the Only One – The Messenger
Lisa Rinna Was Initially 'Very Scared' of Hormone Replacement Therapy. She Isn't the Only One The Messenger
Recommendation and review posted by Bethany Smith